Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Cyclic hexapeptide antifungal agents claimed by Lilly

Nov. 26, 1996

Nyotran progresses towards market introduction

Nov. 25, 1996

New class of antibacterial agents discovered by Zeneca

Nov. 25, 1996

Merck & Co. cephalosporins active against MRSA, MRCNS

Nov. 25, 1996

New carbapenems from Takeda

Nov. 22, 1996

Otsuka describes novel cephems

Nov. 22, 1996

Antimalarial combination demonstrates excellent efficacy

Nov. 21, 1996

Pharmagenesis and Lilly collaborate on development of antifungal agents

Nov. 21, 1996

Xylitol chewing gum effective in preventing otitis media

Nov. 20, 1996

Twelfth approval for Abelcet

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.